Toronto, Ontario–(Newsfile Corp. – July 16, 2025) – DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) (“DiagnaMed” or the “Company”) announces that Jing Peng has stepped down as Chief Financial Officer of the Company, effective immediately. The Board of Directors has appointed Mr. Edward Low as Interim Chief Financial Officer.
Mr. Low has extensive experience in corporate finance and accounting for public companies, including financial reporting, regulatory compliance, and strategic planning. He will oversee the Company’s financial operations during this transition period while the Board evaluates longer-term leadership needs.
The Board thanks Mr. Peng for his service and contributions to DiagnaMed and wishes him well in his future endeavors.
The Company continues to advance its hydrogen development initiatives and enhance operational execution, strategically scaling its platform to capitalize on growth opportunities within the expanding natural hydrogen sector. This includes the ongoing deployment of the QIMC and INRS teams in Northern Ontario.
About DiagnaMed Holdings Corp.
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a Canadian technology innovator specializing in advanced hydrogen extraction technologies designed to support the rapidly growing natural hydrogen industry. Focused on commercial scalability, DiagnaMed aims to deliver cost-effective, sustainable, and efficient hydrogen solutions critical for global energy security and decarbonization. Visit DiagnaMed.com.
For more information, please contact:
John Karagiannidis, President and CEO
DiagnaMed Holdings Corp.
Tel: 514-726-7058
Email: info@diagnamed.com
Website: www.diagnamed.com
#hydrogentech #ontario #hydrogen
